Before you sell to, join or invest in Episteme Prognostics, Inc.
MentionFox check on Episteme Prognostics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/episteme-prognostics-inc-form-d-25000001
Check Episteme Prognostics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Episteme Prognostics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Episteme Prognostics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-10.
Episteme Prognostics, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 10, 2025. The filing reports $550K sold. Its industry group is Biotechnology. It names Surajit Dhara (Executive Officer, Director), Gregory Ho (Director), Jason Rifkin (Director) (SEC Form D, March 10, 2025).
Is this your company?
Sell to companies like Episteme Prognostics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Episteme Prognostics, Inc.
Free to see. No signup.
More on the people and the money behind Episteme Prognostics, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Episteme Prognostics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Episteme Prognostics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Episteme Prognostics, Inc. →Get the full cited report on Episteme Prognostics, Inc.
What the filing shows about Episteme Prognostics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Episteme Prognostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Episteme Prognostics, Inc.'s address as 760 Parkside Avenue, Suite 227C, Brooklyn, NY 11226.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Episteme Prognostics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Episteme Prognostics, Inc. See pricing
Episteme Prognostics, Inc. is a registered filer with the SEC (CIK 1902402) and has filed since 2023-04-14. 5 filings are on record, the latest on 2026-09-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Episteme Prognostics, Inc.'s Form D of 2025-03-10 names Surajit Dhara, Gregory Ho, Jason Rifkin and 1 more as its officers, directors or promoters.
Its new offerings report $8.78M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
By form type: D ×4 · D/A ×2.
| Form | Filed | On EDGAR |
|---|---|---|
| D/A | 2026-09-04 | open |
| D | 2026-09-04 | open |
| D | 2025-03-10 | open |
| D/A | 2023-05-22 | open |
| D | 2023-04-14 | open |
| D | 2022-01-03 | open |
What the filing shows about Episteme Prognostics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Episteme Prognostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Episteme Prognostics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The 6 most recent of 6 filings on CIK 0001902402, filed as Episteme Prognostics, Inc.. Read from the SEC's own submissions feed for this issuer, not from a third party. Incorporated in DE. Full history on sec.gov.
Surajit Dhara is named as Executive Officer and Director on the Form D that Episteme Prognostics, Inc. filed with the SEC on 10 March 2025, one of 4 people that filing names.
Gregory Ho is named as Director on the Form D that Episteme Prognostics, Inc. filed with the SEC on 10 March 2025, one of 4 people that filing names.
Jason Rifkin is named as Director on the Form D that Episteme Prognostics, Inc. filed with the SEC on 10 March 2025, one of 4 people that filing names.
Robert Warren is named as Director on the Form D that Episteme Prognostics, Inc. filed with the SEC on 10 March 2025, one of 4 people that filing names.
4 people named on the filing — 1 holding an executive role and 3 as directors only.
Named as of the 2025-03-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Episteme Prognostics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Episteme Prognostics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Episteme Prognostics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/episteme-prognostics-inc-form-d-25000001